Abstract
Background and hypothesis: There is no method available to predict the relative antianginal efficacy of beta blockers and calcium‐channel antagonists. The present study was undertaken to assess the role of silent ischemic interval (SII) on exercise treadmill test (ETT) as a predictor of response to therapy with metoprolol and diltiazem in patients with stable angina.
Methods: Thirty‐four patients with stable angina were divided into two groups depending upon the presence or absence of an SII gap of at least 1 min between onset of ST depression and appearance of angina on ETT. Metoprolol (50–100 mg twice daily) and diltiazem (60–120 mg three times daily) were randomly assigned for 6 weeks to patients in each group, and then patients were crossed over for further 6 weeks after a washout period of 2 weeks. Antianginal efficacy was assessed by clinical and exercise parameters.
Results: In patients with SII, the clinical responder rate was better with metoprolol than with diltiazem (90 vs. 60%, respectively), and on ETT, metoprolol produced significant improvement in the total exercise time (p<0.01), time to 1 mm ST depression (p < 0.01), time to angina (p < 0.01), and a significant decrease in peak rate‐pressure product (p<0.001), whereas diltiazem had no significant effect on exercise parameters. However, in patients without SII, metoprolol and diltiazem had a similar clinical responder rate (57%), and both produced a significant increase in total exercise time (p < 0.01), time to 1 mm ST depression (p < 0.01), and time to angina (p < 0.01). In addition, metoprolol had a significant effect on peak rate‐pressure product (p < 0.001).
Conclusion: Silent ischemic interval on ETT can be a predictor of response to antianginal therapy in stable angina, as patients with SII respond better to metoprolol and those without SII respond equally to both metoprolol and diltiazem.
Keywords: coronary artery disease, exercise treadmill test, beta blocker, calcium‐channel antagonist, stable angina, metoprolol, diltiazem
Full Text
The Full Text of this article is available as a PDF (496.0 KB).
References
- 1. Kannel WB, Feinleib M: Natural history of angina pectoris in the Framingham Study. Prognosis and survival. Am J Cardiol 1972; 29: 154–163 [DOI] [PubMed] [Google Scholar]
- 2. Elveback LR, Connolly DC, Melton LJ III: Coronary heart disease in residents of Rochester, Minnesota 7. Incidence, 1950 through 1982. Mayo Clin Proc 1986; 61: 896–900 [DOI] [PubMed] [Google Scholar]
- 3. Amsterdam EA, Martschinske R, Laslett LJ, Rutledge JC, Vera Z: Symptomatic and silent myocardial ischemia during exercise testing in coronary artery disease. Am J Cardiol 1986; 58: 43B–46B [DOI] [PubMed] [Google Scholar]
- 4. Sinha N, Ahuja RC, Ravi Kumar R, Bajaj R, Bidwai PS: A randomized crossover trial of metoprolol and diltiazem on exercise induced silent myocardial ischemia in patients with stable angina (abstr). Ind Heart J 1991; 43: 220 [Google Scholar]
- 5. Flitcher GF, Balady G, Froelecher VF, Hartley LH, Haskell WL, Pollock ML: Exercise standards: A statement for health care professionals from the American Heart Association. Circulation 1995; 91: 580–615 [DOI] [PubMed] [Google Scholar]
- 6. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Garden JM, Grumwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV: ACC/AHA/ACP‐ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999; 33: 2092–2197 [DOI] [PubMed] [Google Scholar]
- 7. Maseri A, Chierchia S, Davies G, Glazier J: Mechanisms of ischemie cardiac pain and silent myocardial ischemia. Am J Med 1985; 79 (suppl 3A): 7–11 [DOI] [PubMed] [Google Scholar]
- 8. DeServi S, Ferrario M, Ghio S, Bartoli A, Mussini A, Poma E, Angoli L, Bramucci E, Aimé E, Rondanelli R, Specchia G: Effects of diltiazem on regional coronary hemodynamics during atrial pacing in patients with stable exertional angina: Implications for mechanism of action. Circulation 1986; 73: 1248–1253 [DOI] [PubMed] [Google Scholar]
- 9. Romano M: Long term management of exercise induced myocardial ischemia. Diltiazem versus propanolol—a double blind, crossover study. Int J Clin Pharmacol Ther Toxicol 1986; 84 (10): 551–554 [PubMed] [Google Scholar]
- 10. Stone PH, Gibson RS, Glasser SR, Dewood MA, Parka JD, Kawanishi DT, Crawford MH, Messinco FC, Shook TL, Raby K, Curtis DG, Hoop RS, Young PM, Braunwald E, and the ASIS Study Group : Comparison of propranolol, diltiazem and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990; 82: 1962–1972 [DOI] [PubMed] [Google Scholar]
- 11. Ahuja RC, Sinha N, Kumar RR, Saran RK: Effect of metoprolol and diltiazem on the total ischemic burden in patients with chronic stable angina: A randomized controlled trial. Int J Cardiol 1993; 41: 191–199 [DOI] [PubMed] [Google Scholar]
- 12. Steffensen R, Grande P, Pedersen F, Haunso S: Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia. Int J Cardiol 1993; 40: 143–153 [DOI] [PubMed] [Google Scholar]
- 13. Portegies MCM, Sijbring P, Göbel EJAM, Viersma JW, Lie KI: Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia. Am J Cardiol 1994; 74: 1095–1098 [DOI] [PubMed] [Google Scholar]
- 14. Pratt CM, McMahon RP, Goldstein S, Pepine CJ, Andrews TC, Dyrda I, Frishman WH, Geller NL, Hill JA, Morgan NA, Stone PH, Knatterud GL, Sopko G, Conti R, for the ACIP investigators : Comparison of subgroups assigned to medical regimen used to suppress cardiac ischemia [the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study], Am J Cardiol 1996; 77: B02–B09 [DOI] [PubMed] [Google Scholar]
- 15. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hajan V, Lee BK, Hlatky MA: Meta‐analysis of trials comparing beta blockers, calcium antagonists and nitrates for stable angina. J Am Med Assoc 1999; 281: 1927–1936 [DOI] [PubMed] [Google Scholar]
- 16. Hung J, Lamb IH, Connolly SJ, Jutzy KR, Goris ML, Schroeder JS: The effect of diltiazem and propranolol alone and in combination on exercise performance and left ventricular function in patients with stable effort angina: A double blind, randomized, and placebo controlled study. Circulation 1983; 68: 560–567 [DOI] [PubMed] [Google Scholar]
- 17. Posma JL, van Dijk RB, Lie KI: Sustained release diltiazem vs. metoprolol in stable angina pectoris. Eur Heart J 1989; 10 (10): 923–927 [DOI] [PubMed] [Google Scholar]
- 18. Humen DP, Kostuk WJ: Clinical response and effects on left ventricular function of isosorbide dinitrate added to propanolol or diltiazem monotherapy in patients with chronic stable angina. Can J Cardiol 1991; 7: 74–80 [PubMed] [Google Scholar]
- 19. Nadazdin A, Davies GJ: Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable threshold angina. Am Heart J 1994; 127: 312–317 [DOI] [PubMed] [Google Scholar]
- 20. Cohn PF: Silent myocardial ischemia in patients with a defective anginal warning system. Am J Cardiol 1980; 45: 695–702 [DOI] [PubMed] [Google Scholar]
- 21. Deedwania PC: Silent myocardial ischemia. A clinical perspective. Arch Intern Med 1991; 151: 2373–2382 [PubMed] [Google Scholar]